View in EDS

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.

Saved in:
Bibliographic Details
Title: Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.
Authors: Babiker HM; Mayo Clinic, Jacksonville, FL., Picozzi V; Virginia Mason Medical Center, Seattle, WA., Chandana SR; The Cancer & Hematology Centers, Grand Rapids, MI., Melichar B; Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Kasi A; University of Kansas Cancer Center, Kansas City, KS., Gang J; Changhai Hospital, Shanghai, People's Republic of China., Gallego J; General University Hospital Elche, Elche, Spain., Bullock A; Harvard Medical School, Harvard University, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Chunyi H; Beijing Cancer Hospital, Beijing, People's Republic of China., Wyrwicz L; National Institute of Oncology, Maria Sklodowska Curie National Cancer Research Institute, Warsaw, Poland., Hitre E; National Institute of Oncology, Budapest, Hungary., Osipov A; Cedars-Sinai Medical Center, Los Angeles, CA., de la Fouchardiere C; Centre Léon Bérard, Lyon, France., Ales I; University Hospital Malaga, Malaga, Spain., Dragovich T; Baptist MD Anderson Cancer Center, Jacksonville, FL., Lee W; National Cancer Center, Goyang, Republic of Korea., Feeney K; St John of God Murdoch Hospital, Murdoch, WA, Australia., Philip P; Henry Ford Hospital, Detroit, MI., Ueno M; Kanagawa Cancer Center, Yokohama, Japan., Van Cutsem E; University of Leuven, Leuven, Belgium., Seufferlein T; Ulm University Hospital, Ulm, Germany., Macarulla T; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Corporate Authors: PANOVA-3 Study Investigators
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Jul 20; Vol. 43 (21), pp. 2350-2360. Date of Electronic Publication: 2025 May 31.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40448572
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Babiker+HM%22">Babiker HM</searchLink>; Mayo Clinic, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Picozzi+V%22">Picozzi V</searchLink>; Virginia Mason Medical Center, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Chandana+SR%22">Chandana SR</searchLink>; The Cancer & Hematology Centers, Grand Rapids, MI.<br /><searchLink fieldCode="AU" term="%22Melichar+B%22">Melichar B</searchLink>; Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kasi+A%22">Kasi A</searchLink>; University of Kansas Cancer Center, Kansas City, KS.<br /><searchLink fieldCode="AU" term="%22Gang+J%22">Gang J</searchLink>; Changhai Hospital, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Gallego+J%22">Gallego J</searchLink>; General University Hospital Elche, Elche, Spain.<br /><searchLink fieldCode="AU" term="%22Bullock+A%22">Bullock A</searchLink>; Harvard Medical School, Harvard University, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Chunyi+H%22">Chunyi H</searchLink>; Beijing Cancer Hospital, Beijing, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Wyrwicz+L%22">Wyrwicz L</searchLink>; National Institute of Oncology, Maria Sklodowska Curie National Cancer Research Institute, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Hitre+E%22">Hitre E</searchLink>; National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Osipov+A%22">Osipov A</searchLink>; Cedars-Sinai Medical Center, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22de+la+Fouchardiere+C%22">de la Fouchardiere C</searchLink>; Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Ales+I%22">Ales I</searchLink>; University Hospital Malaga, Malaga, Spain.<br /><searchLink fieldCode="AU" term="%22Dragovich+T%22">Dragovich T</searchLink>; Baptist MD Anderson Cancer Center, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Lee+W%22">Lee W</searchLink>; National Cancer Center, Goyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Feeney+K%22">Feeney K</searchLink>; St John of God Murdoch Hospital, Murdoch, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Philip+P%22">Philip P</searchLink>; Henry Ford Hospital, Detroit, MI.<br /><searchLink fieldCode="AU" term="%22Ueno+M%22">Ueno M</searchLink>; Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Van+Cutsem+E%22">Van Cutsem E</searchLink>; University of Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Seufferlein+T%22">Seufferlein T</searchLink>; Ulm University Hospital, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Macarulla+T%22">Macarulla T</searchLink>; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PANOVA-3+Study+Investigators%22">PANOVA-3 Study Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2025 Jul 20; Vol. 43 (21), pp. 2350-2360. <i>Date of Electronic Publication: </i>2025 May 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40448572
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO-25-00746
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2350
    Titles:
      – TitleFull: Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Babiker HM
      – PersonEntity:
          Name:
            NameFull: Picozzi V
      – PersonEntity:
          Name:
            NameFull: Chandana SR
      – PersonEntity:
          Name:
            NameFull: Melichar B
      – PersonEntity:
          Name:
            NameFull: Kasi A
      – PersonEntity:
          Name:
            NameFull: Gang J
      – PersonEntity:
          Name:
            NameFull: Gallego J
      – PersonEntity:
          Name:
            NameFull: Bullock A
      – PersonEntity:
          Name:
            NameFull: Chunyi H
      – PersonEntity:
          Name:
            NameFull: Wyrwicz L
      – PersonEntity:
          Name:
            NameFull: Hitre E
      – PersonEntity:
          Name:
            NameFull: Osipov A
      – PersonEntity:
          Name:
            NameFull: de la Fouchardiere C
      – PersonEntity:
          Name:
            NameFull: Ales I
      – PersonEntity:
          Name:
            NameFull: Dragovich T
      – PersonEntity:
          Name:
            NameFull: Lee W
      – PersonEntity:
          Name:
            NameFull: Feeney K
      – PersonEntity:
          Name:
            NameFull: Philip P
      – PersonEntity:
          Name:
            NameFull: Ueno M
      – PersonEntity:
          Name:
            NameFull: Van Cutsem E
      – PersonEntity:
          Name:
            NameFull: Seufferlein T
      – PersonEntity:
          Name:
            NameFull: Macarulla T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 07
              Text: 2025 Jul 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 21
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1